does wellmark cover glp-1 drugs Insurance: How to Find Out if Your Medication Is Covered Long-Term Weight Management Requires More

Orforglipron is an oral GLP-1 agonist that could eliminate the need for injections entirely

Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin

Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): A randomized clinical trial

Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists

The investigators are assessing a three-point major adverse cardiovascular event endpoint (myocardial infarction, stroke, and cardiovascular death), over an estimated maximum of 54months (NCT04255433, estimated study completion in October 2024)

Tighter Policy Rules: To curb misuse, insurance companies may tighten approval requirementssuch as demanding more detailed diagnostic reports, BMI documentation, or proof of failed lifestyle interventiondelaying access for patients with legitimate needs